OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The influence of HLA genotype on the severity of COVID‐19 infection
David Langton, Stephen C Bourke, Benedicte A. Lie, et al.
HLA (2021) Vol. 98, Iss. 1, pp. 14-22
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Whole-genome sequencing reveals host factors underlying critical COVID-19
Athanasios Kousathanas, Erola Pairo‐Castineira, Konrad Rawlik, et al.
Nature (2022) Vol. 607, Iss. 7917, pp. 97-103
Open Access | Times Cited: 271

A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection
Danillo G. Augusto, Lawton D. Murdolo, Demetra S.M. Chatzileontiadou, et al.
Nature (2023) Vol. 620, Iss. 7972, pp. 128-136
Open Access | Times Cited: 143

COVID‐19 in children. II: Pathogenesis, disease spectrum and management
Annaleise R. Howard‐Jones, David Burgner, Nigel Crawford, et al.
Journal of Paediatrics and Child Health (2021) Vol. 58, Iss. 1, pp. 46-53
Open Access | Times Cited: 104

Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form
Анна Малкова, Igor Kudryavtsev, Анна Старшинова, et al.
Pathogens (2021) Vol. 10, Iss. 11, pp. 1408-1408
Open Access | Times Cited: 86

HLA variation and antigen presentation in COVID-19 and SARS-CoV-2 infection
Danillo G. Augusto, Jill A. Hollenbach
Current Opinion in Immunology (2022) Vol. 76, pp. 102178-102178
Open Access | Times Cited: 64

Human Leukocyte Antigen (HLA) System: Genetics and Association with Bacterial and Viral Infections
Sadeep Medhasi, Narisara Chantratita
Journal of Immunology Research (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 54

The association of COVID-19 severity and susceptibility and genetic risk factors: A systematic review of the literature
Angela Ishak, Meghana Mehendale, Mousa M. AlRawashdeh, et al.
Gene (2022) Vol. 836, pp. 146674-146674
Open Access | Times Cited: 39

Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms
Brent Brown, Vanshika Ojha, Ingo Fricke, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 37

The role of HLA genetic variants in COVID‐19 susceptibility, severity, and mortality: A global review
Taraneh Hoseinnezhad, Nasrin Soltani, Sarina Ziarati, et al.
Journal of Clinical Laboratory Analysis (2024) Vol. 38, Iss. 1-2
Open Access | Times Cited: 12

MHC Variants Associated With Symptomatic Versus Asymptomatic SARS-CoV-2 Infection in Highly Exposed Individuals
Erick C. Castelli, Mateus Vidigal de Castro, Michel Satya Naslavsky, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 46

Association of HLA gene polymorphism with susceptibility, severity, and mortality of COVID‐19: A systematic review
Paroma Deb, Kaniz E Zannat, Shiny Talukder, et al.
HLA (2022) Vol. 99, Iss. 4, pp. 281-312
Open Access | Times Cited: 33

The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic
Maria Karoliny da Silva Torres, Carlos David Araújo Bichara, Maria de Nazaré do Socorro de Almeida, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 30

Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies
Shizuko Sei, Aysel Ahadova, Derin B. Keskin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16

HLA Variation and SARS-CoV-2 Specific Antibody Response
Dawit Wolday, Chun Yiu Jordan Fung, Gregory Morgan, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 906-906
Open Access | Times Cited: 16

Impact of SARS-CoV-2 pre-delta/delta and omicron variants on clinical outcomes in a systemic lupus erythematosus cohort from Puerto Rico
Lilliana Serrano-Arroyo, Ariana González-Meléndez, Rafael Ríos-Rivera, et al.
Lupus (2025)
Closed Access

The association of human leucocyte antigen (HLA) alleles with COVID‐19 severity: A systematic review and meta‐analysis
Zorana Dobrijević, Nikola Gligorijević, Miloš Šunderić, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 23

Polymorphism of the HLA system and weak antibody response to BNT162b2 mRNA vaccine
Roberto Crocchiolo, Anna Maria Gallina, Arianna Pani, et al.
HLA (2022) Vol. 99, Iss. 3, pp. 183-191
Closed Access | Times Cited: 22

Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22

HLA-DQB1*05:03 is associated with an increased risk of COVID-19 progression in the Bulgarian population
Tsvetelin Lukanov, Anastasiya Mihaylova, Bushra Al Hadra, et al.
Human Immunology (2025) Vol. 86, Iss. 1, pp. 111228-111228
Closed Access

A Structural Voyage Toward the Landscape of Humoral and Cellular Immune Escapes of SARSCoV‐2
Jun Liu, Yan Wu, George F. Gao
Immunological Reviews (2025) Vol. 330, Iss. 1
Closed Access

COVID-19 ‘asymptomatic’ patients: an old wives’ tale
Dimitra S. Mouliou, Konstantinos I. Gourgoulianis
Expert Review of Respiratory Medicine (2022), pp. 1-9
Closed Access | Times Cited: 21

Page 1 - Next Page

Scroll to top